• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与妇科恶性肿瘤相关的高钙血症:生化特征

Hypercalcemia associated with gynecologic malignancies: biochemical characterization.

作者信息

Stewart A F, Romero R, Schwartz P E, Kohorn E I, Broadus A E

出版信息

Cancer. 1982 Jun 1;49(11):2389-94. doi: 10.1002/1097-0142(19820601)49:11<2389::aid-cncr2820491128>3.0.co;2-w.

DOI:10.1002/1097-0142(19820601)49:11<2389::aid-cncr2820491128>3.0.co;2-w
PMID:7074551
Abstract

Fasting calcium excretion, renal phosphorus threshold, plasma 1,25 dihydroxyvitamin D, immunoreactive PTH, nephrogenous cyclic AMP excretion, and tumor burden were assessed in nine patients with gynecologic neoplasms and hypercalcemia. Gynecologic neoplasms were responsible for hypercalcemia in seven of 34 (20.5%) consecutive patients with malignancy-associated hypercalcemia. The tumor burden in each patient was large. Three of four endometrial carcinomas contained squamous elements. All patients displayed biochemical evidence of nonparathyroid humorally mediated hypercalcemia (bone resorption). Treatment of hypercalcemia did not appear to diminish production of the humoral calcemic factor but eradication of tumor eliminated biochemical evidence of the humoral syndrome. It can be concluded that (1) gynecologic neoplasms are a frequent cause of malignancy-associated hypercalcemia, (2) humoral mechanisms appeared to be responsible for the hypercalcemia in 100% of the patients in this series, (3) squamous features occur with unexpected frequency in hypercalcemic endometrial carcinoma, (4) the presence of hypercalcemia connotes a large tumor burden, and (5) treatment directed at the neoplasm (but not treatment directed at hypercalcemia) may eliminate evidence of ectopic calcemic hormone production.

摘要

对9例患有妇科肿瘤并伴有高钙血症的患者进行了空腹钙排泄、肾磷阈值、血浆1,25 - 二羟维生素D、免疫反应性甲状旁腺激素、肾源性环磷酸腺苷排泄及肿瘤负荷的评估。在34例连续性恶性肿瘤相关性高钙血症患者中,有7例(20.5%)的高钙血症由妇科肿瘤引起。每位患者的肿瘤负荷都很大。4例子宫内膜癌中有3例含有鳞状成分。所有患者均表现出非甲状旁腺激素介导的高钙血症(骨吸收)的生化证据。高钙血症的治疗似乎并未减少体液性钙调节因子的产生,但肿瘤根除后消除了体液综合征的生化证据。可以得出以下结论:(1)妇科肿瘤是恶性肿瘤相关性高钙血症的常见病因;(2)在本系列研究中,100%的患者高钙血症似乎由体液机制引起;(3)高钙血症型子宫内膜癌中鳞状特征出现的频率出乎意料;(4)高钙血症的存在意味着肿瘤负荷大;(5)针对肿瘤的治疗(而非针对高钙血症的治疗)可能消除异位钙调节激素产生的证据。

相似文献

1
Hypercalcemia associated with gynecologic malignancies: biochemical characterization.与妇科恶性肿瘤相关的高钙血症:生化特征
Cancer. 1982 Jun 1;49(11):2389-94. doi: 10.1002/1097-0142(19820601)49:11<2389::aid-cncr2820491128>3.0.co;2-w.
2
Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups.癌症相关性高钙血症患者的生化评估:体液性和非体液性分组的证据
N Engl J Med. 1980 Dec 11;303(24):1377-83. doi: 10.1056/NEJM198012113032401.
3
Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.在健康人类志愿者中,对人甲状旁腺激素相关蛋白-(1-36)[hPTHrP-(1-36)]与hPTH-(1-34)持续输注对血清钙、血浆1,25-二羟基维生素D浓度及钙排泄分数的直接比较。
J Clin Endocrinol Metab. 2003 Apr;88(4):1603-9. doi: 10.1210/jc.2002-020773.
4
Mechanisms of hypercalcemia in patients with head and neck cancer.
Head Neck Surg. 1982 Nov-Dec;5(2):125-9. doi: 10.1002/hed.2890050207.
5
Nephrogenous cyclic AMP, adenylate cyclase-stimulating activity, and the humoral hypercalcemia of malignancy.
Recent Prog Horm Res. 1986;42:705-50. doi: 10.1016/b978-0-12-571142-5.50021-5.
6
A case of leiomyosarcoma associated with humoral hypercalcemia of malignancy: demonstration of biological and immunological activities of parathyroid hormone-related protein in the tumor extract.一例与恶性肿瘤体液性高钙血症相关的平滑肌肉瘤:肿瘤提取物中甲状旁腺激素相关蛋白的生物学和免疫活性证明
Jpn J Cancer Res. 1989 Jul;80(7):643-8. doi: 10.1111/j.1349-7006.1989.tb01691.x.
7
Malignancy-associated hypercalcemia: evaluation with a cytochemical bioassay for parathyroid hormone.恶性肿瘤相关性高钙血症:采用甲状旁腺激素细胞化学生物测定法进行评估
J Clin Endocrinol Metab. 1981 Nov;53(5):899-904. doi: 10.1210/jcem-53-5-899.
8
Humoral hypercalcemia of malignancy in canine lymphosarcoma.
Endocrinology. 1988 Feb;122(2):602-8. doi: 10.1210/endo-122-2-602.
9
Humoral hypercalcemia of malignancy: a syndrome in search of a hormone.
Am J Med. 1982 Nov;73(5):751-5. doi: 10.1016/0002-9343(82)90419-3.
10
Biochemical and histomorphometric characterization of a rat model for humoral hypercalcemia of malignancy.
Endocrinology. 1984 Mar;114(3):888-96. doi: 10.1210/endo-114-3-888.

引用本文的文献

1
Case Report: Life-threatening hypercalcemia associated with MMR-deficient endometrial carcinoma secreting parathyroid hormone.病例报告:MMR 缺陷型子宫内膜癌分泌甲状旁腺激素导致危及生命的高钙血症。
Front Endocrinol (Lausanne). 2023 Jan 31;14:1125822. doi: 10.3389/fendo.2023.1125822. eCollection 2023.
2
Hypercalcemia Due to Paraneoplastic Production of 1,25- Dihydroxyvitamin D in a Young Female with Dysgerminoma.一名患有无性细胞瘤的年轻女性因副肿瘤性产生1,25-二羟维生素D导致高钙血症
Cureus. 2019 Nov 8;11(11):e6097. doi: 10.7759/cureus.6097.
3
Inpatient management of hypercalcemia portends a poor prognosis among gynecologic oncology patients: A trigger to initiate hospice care?
妇科肿瘤患者高钙血症的住院治疗预示着预后不良:是否是启动临终关怀的触发因素?
Gynecol Oncol Rep. 2019 Jan 26;28:1-5. doi: 10.1016/j.gore.2019.01.005. eCollection 2019 May.
4
Response of paraneoplastic syndromes to antineoplastic therapy.副肿瘤综合征对抗肿瘤治疗的反应。
West J Med. 1986 May;144(5):580-5.